Cargando…

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees

To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29–December 18, 2021. Vaccinees with mild or asymptomatic infection shed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Kenichiro, Ishikane, Masahiro, Ujiie, Mugen, Iwamoto, Noriko, Okumura, Nobumasa, Sato, Testsuro, Nagashima, Maki, Moriya, Ataru, Suzuki, Michiyo, Hojo, Masayuki, Kanno, Takayuki, Saito, Shinji, Miyamoto, Sho, Ainai, Akira, Tobiume, Minoru, Arashiro, Takeshi, Fujimoto, Tsuguto, Saito, Tomoya, Yamato, Masaya, Suzuki, Tadaki, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045443/ https://www.ncbi.nlm.nih.gov/pubmed/35290176 http://dx.doi.org/10.3201/eid2805.220197

Ejemplares similares

Varicella pneumonia in an immunocompetent, unvaccinated man: A case report
por: Okumura, Nobumasa, et al.
Publicado: (2021)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
por: Maruki, Taketomo, et al.
Publicado: (2021)

Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan
por: Yamamoto, Kei, et al.
Publicado: (2021)

480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
por: KAMEGAI, K O H E I, et al.
Publicado: (2023)

A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Predictive Performance of Gram Staining of Catheter Tips for Candida Catheter-Related Bloodstream Infections
por: Yamada, Gen, et al.
Publicado: (2022)

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan
por: Fujino, Takahisa, et al.
Publicado: (2021)

A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity
por: Moriyama, Yuki, et al.
Publicado: (2022)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19
por: Ishikane, Masahiro, et al.
Publicado: (2022)

Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study
por: Yano, Rina, et al.
Publicado: (2023)

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023)

Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study
por: Tomita, Noriko, et al.
Publicado: (2023)

Effect of temperature on the infectivity of COVID-19
por: Ujiie, Mugen, et al.
Publicado: (2020)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
por: Inada, Makoto, et al.
Publicado: (2022)

Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test
por: Suzuki, Michiyo, et al.
Publicado: (2023)

Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity
por: Nakamura, Keiji, et al.
Publicado: (2020)

Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological Perspective
por: Iida, Shun, et al.
Publicado: (2021)

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
por: Hemmi, Takuya, et al.
Publicado: (2022)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients
por: Nomoto, Hidetoshi, et al.
Publicado: (2021)

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
por: Miyamoto, Sho, et al.
Publicado: (2023)

Interferon lambda 3 in the early phase of coronavirus disease‐19 can predict oxygen requirement
por: Suzuki, Tetsuya, et al.
Publicado: (2022)

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers()
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital
por: Morioka, Shinichiro, et al.
Publicado: (2020)

1071. Retrospective study evaluating the cytokine dynamics in COVID-19 patients who were treated with casirivimab/imdevimab
por: Sugita, Akiho, et al.
Publicado: (2022)

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
por: Kamegai, Kohei, et al.
Publicado: (2022)

Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan
por: Ujiie, Mugen, et al.
Publicado: (2021)

Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19
por: Hosoya, Tadashi, et al.
Publicado: (2023)

Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses
por: Kotani, Osamu, et al.
Publicado: (2021)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020
por: Arima, Yuzo, et al.
Publicado: (2020)

201. Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-Hemolytic Streptococci Species: A Single-Center Retrospective Study
por: Inada, Makoto, et al.
Publicado: (2023)

Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
por: Ujiie, Mugen
Publicado: (2022)

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies
por: Inada, Makoto, et al.
Publicado: (2021)

External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan
por: Yamada, Gen, et al.
Publicado: (2021)

Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
por: Kinoshita, Ryo, et al.
Publicado: (2023)

Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction
por: Yamamoto, Kei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m5llkik0lkifuc2d1dktmlqkg5